The Effects of GLP-1 on Glucose Metabolism: A Comprehensive Review
Glucagon-like peptide-1 (GLP-1) has emerged as a powerful player in regulating metabolism and a promising therapeutic target for various chronic diseases. This review delves into the physiological roles of GLP-1, exploring its impact on glucose homeostasis, insulin secretion, and satiety. We examine the compelling evidence supporting GLP-1 receptor agonists (GLP-1RAs) in managing type 2 diabetes and obesity.Physiological Roles of GLP-1
GLP-1 is a peptide hormone released from the intestinal tract in response to food intake. It plays a central role in coordinating postprandial glucose homeostasis through actions on insulin secretion, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-2 (GLP-2). GLP-1 has been shown to have a strong blood glucose-lowering effect through pharmacological actions, such as gastric emptying and appetite suppression, in addition to promoting insulin secretion and inhibiting glucagon secretion.Impact on Glucose Metabolism

As we can see from the illustration, Effects Of Glp 1 On Glucose Metabolism has many fascinating aspects to explore.
GLP-1 has been demonstrated to have a significant impact on glucose metabolism, including:- Stimulating insulin secretion from pancreatic beta cells
- Suppressing glucagon secretion from pancreatic alpha cells
- Regulating glucose-dependent insulinotropic polypeptide (GIP) secretion
- Slowing gastric emptying and reducing appetite
- Improving insulin sensitivity and glucose uptake in skeletal muscle
- Improving glycemic control
- Reducing body weight
- Lowering blood pressure
- Improving lipid profiles
- Reducing cardiovascular risk
